Clinical inertia in individualising care for diabetes: is there time to do more in type 2 diabetes?
Clinical inertia in individualising care for diabetes: is there time to do more in type 2 diabetes?
复制标题
DOI：
10.1007/s13300-014-0077-8
复制
发表时间：
2014-12
期刊：
影响因子：
3.8
通讯作者：
Paldanius, Paivi
中科院分区：
文献类型：
--
作者：
Strain, William David;Blueher, Matthias;Paldanius, Paivi
临床惰性定义为未能建立适当的目标和升级治疗以实现治疗目标。它占糖尿病管理中未能实现目标的很大比例，并导致每年多达20万例糖尿病相关不良结局。尽管人们对这一现象的认识不断提高，并且有更新的、耐受性更好的药物用于控制糖尿病，但在过去十年中，临床惰性的患病率几乎没有改善。虽然临床实践中很常见，但临床惰性似乎不会影响临床试验。从这些随机对照试验中可以获得一些经验教训，这些经验教训可能会改善对糖尿病患者的护理。这些干预措施中的关键是良好的教育，明确的治疗策略和更多的时间进行医生和患者之间的互动，所有这些似乎都可以减少临床惰性，正如临床试验的“安慰剂效应”所证明的那样。我们计划在这里回顾一下，从临床试验中可以学到的教训，以及这些教训如何转化为更好地照顾糖尿病患者。本文的在线版本（doi：10.1007/s13300-014-0077-8）包含补充材料，可供授权用户使用。
Clinical inertia is defined as the failure to establish appropriate targets and escalate treatment to achieve treatment goals. It accounts for a significant proportion of failure to achieve targets in the management of diabetes and contributes to up to 200,000 adverse diabetes- related outcomes per year. Despite a growing awareness of the phenomenon, and newer, better-tolerated agents for the control of diabetes, there has been little improvement over the last decade in the prevalence of clinical inertia. Although common-place in clinical practice, clinical inertia does not appear to affect clinical trials. There are lessons that may be translated from these randomised controlled trials to clinical practice, which that may improve the care for those with diabetes. Key amongst these interventions are good education, clear treatment strategy and more time for interaction between physician and patients, all of which appears to reduce clinical inertia as evidenced by the “placebo effect” of clinical trials. We plan to review here, the lessons that can be learnt from clinical trials and how these may translate to better care for people with diabetes. The online version of this article (doi:10.1007/s13300-014-0077-8) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子：
3.8
作者：
Garcia-Perez, Luis-Emilio;Alvarez, Maria;Dilla, Tatiana;Gil-Guillen, Vicente;Orozco-Beltran, Domingo
通讯作者：
Orozco-Beltran, Domingo
影响因子：
16.2
作者：
Hoerger, Thomas J.;Gregg, Edward W.;Saaddine, Jinan B.
通讯作者：
Saaddine, Jinan B.
影响因子：
6.2
作者：
Braga, Manoela F. B.;Casanova, Amparo;Leiter, Lawrence A.
通讯作者：
Leiter, Lawrence A.
影响因子：
168.9
作者：
Strain, W. David;Lukashevich, Valentina;Paldanius, Paeivi Maria
通讯作者：
Paldanius, Paeivi Maria
影响因子：
2.3
作者：
Yoshioka, Narihito;Ishii, Hitoshi;Iwamoto, Yasuhiko
通讯作者：
Iwamoto, Yasuhiko